These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
876 related articles for article (PubMed ID: 29385876)
1. Antiphospholipid syndrome, "the best prophet of the future". Amengual O; Atsumi T Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876 [TBL] [Abstract][Full Text] [Related]
2. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome. Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664 [TBL] [Abstract][Full Text] [Related]
6. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies: evaluation of the thrombotic risk. Devreese KM Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657 [TBL] [Abstract][Full Text] [Related]
10. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
12. Interpretation and recommended testing for antiphospholipid antibodies. Galli M Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116 [TBL] [Abstract][Full Text] [Related]